The Effect of Drugs on Hair

  • N. B. Simpson
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 87 / 2)

Abstract

Hair has lost most of its physiological importance in humans. However, alteration of hair growth, whether natural or drug-induced, causes great psycho-social upset. The majority of the published literature concerning the effect of drugs on hair has therefore come from clinicians, with smaller contributions from biochemists and physiologists. Owing to the large inter-species differences in hair growth and moulting patterns, results from animals have been cited only where they contribute to the understanding of the situation that occurs in humans.

Keywords

Colchicine Fenton Chloroquine Levamisole Procainamide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham G, Maroulis G, Buster J, Chang J, Marshall J (1976) Effect of dexamethasone on serum Cortisol and androgen levels in hirsute patients. Obstet Gynecol 47:395–402PubMedGoogle Scholar
  2. Andreyko JL, Monroe SE, Jaffe RB (1986) Treatment of hirsutism with a gonadotrophinreleasing hormone agonist. J Clin Endocrinol Metab 63:854–859PubMedCrossRefGoogle Scholar
  3. Bardin WC, Lipsett MB (1976) Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism and polycystic ovaries. J Clin Invest 46:891–902CrossRefGoogle Scholar
  4. Barth JH, Darley CR, Gibson JR (1985) Squaric acid dibutyl ester in the treatment of alopecia areata. Dermatologica 170:40–42PubMedCrossRefGoogle Scholar
  5. Bazzano GS, Terezakas N, Galen W (1986) Topical tretinoin for hair growth promotion. J Am Acad Dermatol 15:880–883PubMedCrossRefGoogle Scholar
  6. Braun-Falco O (1961) Klinik und Pathomechanismus der Endoxan-Alopecia als Beitrag zum Wesen cytostatischer Alopecia. Arch Klin Exp Dermatol 212:194–216CrossRefGoogle Scholar
  7. Casey JH, Burger HG, Kent JR, Kellie AE, Moxham A, Nabarro J, Nabarro JDN (1966) Treatment of hirsutism by adrenal and ovarian suppression. J Clin Endocrinol Metab 26:1370–1374PubMedCrossRefGoogle Scholar
  8. Chapman MG, Dowsett M, Dewhurst CJ, Jeffcoate SL (1985) Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism. Br J Obstet Gynaecol 92:983–985PubMedCrossRefGoogle Scholar
  9. Chapman MG, Katz M, Dowsett M, Hague W, Jeffcoate SL, Dewhurst CJ (1986) Spironolactone in the treatment of hirsutism. Acta Obstet Gynecol Scand 65:349–350PubMedCrossRefGoogle Scholar
  10. Cohen S (1962) Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 237:1555–1562PubMedGoogle Scholar
  11. Crounse RG, Van Scott EJ (1960) Changes in scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs. J Invest Dermatol 35:83–90PubMedGoogle Scholar
  12. Cullberg G, Hamberger L, Mattsson L-A, Mobacken H, Samsioe G (1985) Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome. Acta Obstet Gynecol Scand 64:195–202PubMedCrossRefGoogle Scholar
  13. Daman LA, Rosenberg EW (1978) Treatment of alopecia areata with DNCB. Arch Dermatol 114:1036–1038PubMedCrossRefGoogle Scholar
  14. Dawber RPR, Connor BL (1971) Pregnancy, hair loss and the pill. Br Med J iv:234CrossRefGoogle Scholar
  15. De Villez RL (1985) Topical minoxidil therapy in hereditary androgenetic alopecia. Arch Dermatol 121:197–202PubMedCrossRefGoogle Scholar
  16. Dewhurst CJ, Underhill R, Goldman S, Mansfield M (1977) The treatment of hirsutism with cyproterone acetate (an antiandrogen). Br J Obstet Gynaecol 84:119–123PubMedCrossRefGoogle Scholar
  17. Dewis P, Petsos P, Newman M, Anderson DC (1985) Thre treatment of hirsutism with a combination of desogestrel and ethinyl oestradiol. Clin Endocrinol (Oxf) 22:29–36CrossRefGoogle Scholar
  18. Dorrington-Ward P, McCartney ACE, Holland S, Scully J, Carter G, Alaghband-Zadeh J, Wise P (1985) The effect of spironolactone on hirsutism and female androgen metabolism. Clin Endocrinol (Oxf) 23:161–167CrossRefGoogle Scholar
  19. Ebling FJ, Thomas AK, Cooke ID, Randall VA, Skinner J, Cawood M (1977) Effect of cyproterone acetate on hair growth, sebaceous secretion and endocrine parameters in a hirsute subject. Br J Dermatol 97:371–381PubMedCrossRefGoogle Scholar
  20. Ekoe TM, Burchardt P, Revedi B (1980) Treatment of hirsutism, acne and alopecia with cyproterone acetate. Dermatologica 160:398–404PubMedCrossRefGoogle Scholar
  21. Ettinger B, Golditch IM (1977) Medroxyprogesterone acetate for the evaluation of hypertestosteronism in hirsute women. Fertil Steril 28:1285–1288PubMedGoogle Scholar
  22. Fazekas AG, Sandor T (1972) Metabolism of androgens by isolated human hair follicles. J Steroid Biochem 3:485–491PubMedCrossRefGoogle Scholar
  23. Feil VJ, Lamoureux C-JH (1974) Alopecia activity of cyclophosphamide metabolites and related compounds in sheep. Cancer Res 34:2596–2598PubMedGoogle Scholar
  24. Fenton DA, Wilkinson JD (1983) Topical minoxidil in the treatment of alopecia areata. Br Med J [Clin Res] 287:1015–1017CrossRefGoogle Scholar
  25. Fenton DA, English JS, Wilkinson JD (1982) Reversal of male pattern baldness, hypertrichosis and accelerated hair and nail growth in patients receiving benoxaprofen. Br Med J [Clin Res] 284:1228–1229CrossRefGoogle Scholar
  26. Fenton DA, Wilkinson JD, Young E, Dodd H, Simpson NB, Desselberger U, Friedman P, White S, Hinchley H (1985) Topical minoxidil in the treatment of alopecia totalis (poster). Br J Dermatol 113 [Suppl 29]:31CrossRefGoogle Scholar
  27. Galbrath GMP, Thiers BH, Fudenberg HH (1984) An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency. J Am Acad Dermatol 11:224–230CrossRefGoogle Scholar
  28. Gebhart W, Schmidt JB, Schemper M, Spona J, Kopsa H, Zazgornik J (1986) Cyclosporin-A induced hair growth in human renal allograft recipients and alopecia areata. Arch Dermatol Res 278:238–240PubMedCrossRefGoogle Scholar
  29. Giacometti L (1965) The anatomy of the human scalp. In: Montagna W, Dobson RL (eds) Hair growth. Pergamon, Oxford (Advances in biology of skin, vol IX)Google Scholar
  30. Gillespie JM, Marshall RC, Moore GPM, Panaretto BA, Robertson DM (1982) Changes in the proteins of wool following treatment of sheep with EGF. J Invest Dermatol 79:197–200PubMedCrossRefGoogle Scholar
  31. Givens JR, Anderson RN, Ragland JB, Wiser WL, Umstot ES (1975) Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17 hydroxyprogesterone, Cortisol, LH and FSH to dexamethasone and ½ unit of ACTH. J Clin Endocrinol Metab 40:988–1000PubMedCrossRefGoogle Scholar
  32. Gompel A, Wright F, Kuttenn F, Mauvais-Jarvais P (1986) Contribution of plasma androstenedione to 5 alpha-androstanediol glucuronide in women with idiopathic hirsutism. J Clin Endocrinol Metab 62:441–444PubMedCrossRefGoogle Scholar
  33. Graham RM, James MP, Ferguson DJP, Guerrier CW (1985) Acquired kinking of the hair associated with etretinate therapy. Clin Exp Dermatol 10:426–431PubMedCrossRefGoogle Scholar
  34. Green MR, Couchman JR (1985) Differences in human skin between the epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition. J Invest Dermatol 85:239–245PubMedCrossRefGoogle Scholar
  35. Greep N, Hoopes M, Horton R (1986) Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women. J Clin Endocrinol Metab 62:22–27PubMedCrossRefGoogle Scholar
  36. Gregory H (1975) Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 257:325–327PubMedCrossRefGoogle Scholar
  37. Griffin JE, Leshin M, Wilson JD (1982) Androgen resistance syndromes. Am J Physiol 243:81–87Google Scholar
  38. Griffiths WAD (1973) Diffuse hair loss and oral contraceptives. Br J Dermatol 88:31–36Google Scholar
  39. Groveman HD, Ganiats T, Klauber MR (1985) Lack of efficacy of polysorbate 60 in the treatment of male pattern baldness. Arch Intern Med 145:1454–1458PubMedCrossRefGoogle Scholar
  40. Hamilton JB (1942) Male hormone stimulation is prerequisite as an incitant in common baldness. Am J Anat 71:451–480CrossRefGoogle Scholar
  41. Hamilton JB (1958) Age, sex and genetic factors in the regulation of hair growth in man: a comparison of Caucasian and Japanese populations. In: Montagna W, Ellis RA (eds) The biology of hair growth. Academic, New York, pp 399–433Google Scholar
  42. Hammerstein J, Cupuceancu B (1969) Behandlung des Hirsutismus mit Cyproteronacetat. Dtsch Med Wochenschr 94:829–834PubMedCrossRefGoogle Scholar
  43. Happle R, Kalvaran KJ, Buchner U, Echternecht-Happle K, Goggleman W, Summer JH (1980) Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester. Dermatologica 161:289–297PubMedCrossRefGoogle Scholar
  44. Happle R, Hausen BM, Wiesner-Menzel L (1983) Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 63:49–52Google Scholar
  45. Harper JI, Kendra JR, Desai S, Staughton RCD, Barrett AJ, Hobbs JR (1984) Dermatological aspects of the use of cyclosporin A for prophylaxis of graft versus host disease. Br J Dermatol 110:469–474PubMedCrossRefGoogle Scholar
  46. Hay JB, Hodgins MB (1978) Distribution of androgen metabolising enzymes in isolated tissues of human forehead and axillary skin. J Endocrinol 79:29–39PubMedCrossRefGoogle Scholar
  47. Hodgins MB; Murad S, Simpson NB (1985) A search for variation in hair follicle androgen metabolism which might be linked to male pattern baldness. Br J Dermatol 113:794 (abstr)Google Scholar
  48. Holdaway IM; Croxson MS, Ibbertson HK, Sheehan A, Knox B, France J (1985) Cyproterone acetate as initial treatment and maintenance therapy for hirsutism. Acta Endocrinol (Copenh) 109:522–529Google Scholar
  49. Hollis DE, Chapman RE, Panaretto BA, Moore GPM (1983) Morphological changes in the skin and wool fibres of merino sheep infused with mouse epidermal growth factor. Aust J Biol Sci 36:419–434PubMedGoogle Scholar
  50. Horne KA, Jahoda CA, Oliver RF (1986) Whisker growth induced by implantation of cultured virbrissa dermal papilla cells in the adult rat. J Embryol Exp Morphol 97:111–124PubMedGoogle Scholar
  51. Johnson GA, Barsuhn KJ, McCall JM (1982) Sulfation of minoxidil by liver sulfotransferase. Biochem Pharmacol 31:2949–2954PubMedCrossRefGoogle Scholar
  52. Katsuoka K, Schell H, Wessel B, Hornstein OP (1987) Effects of epidermal growth factor, fibroblast growth factor, minoxidil and hydrocortisone on growth kinetics of human hair bulb papilla cells and root sheath fibroblasts cultured in vitro. Arch Dermatol Res 279:247–250PubMedCrossRefGoogle Scholar
  53. Kligman AM (1959) The human hair cycle. J Invest Dermatol 33:307–316PubMedCrossRefGoogle Scholar
  54. Kligman AM (1961) Pathologic dynamics of human hair loss I. Telogen effluvium. Arch Dermatol Syphilol 83:175–198CrossRefGoogle Scholar
  55. Koblenzer PJ; Baker L (1968) Hypertrichosis lanuginosa associated with diazoxide therapy in prepubertal children: a clinicopathologic study. Ann NY Acad Sci 150:373–383PubMedCrossRefGoogle Scholar
  56. Koranda FC (1974) Hair changes in immunosuppressed patients. In: Brown AC (ed) First human hair symposium. Medcom, New York, p 91Google Scholar
  57. Kutten F, Mowszowicz I, Mauvais-Jarvis P (1980) Androgen metabolism on human skin. In: Mauvais-Jarvis P, Vickers CFH, Wepierre J (eds) Percutaneous absorption of steroids. Academic,London, pp 99–121Google Scholar
  58. Malkinson FD, Lynfield YL (1959) Colchicine alopecia. J Invest Dermatol 33:371–384PubMedCrossRefGoogle Scholar
  59. Marks CG (1974) Localised hirsuties following compression sclerotherapy with sodium tetradecyl sulphate. Br J Surg 61:127–128PubMedCrossRefGoogle Scholar
  60. Mauvais-Jarvis P (1977) Androgen metabolism in human skin: mechanisms of control. In: Martini L, Motta M (eds) Androgens and antiandrogens. Raven, New York, pp 229–245Google Scholar
  61. Menard RH, Stripp B, Gillette JR (1974) Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone. J Biol Chem 254:1726–1733Google Scholar
  62. Moore GPM, Panaretto BA, Wallace ALC (1984) Treatment of ewes at different stages of pregnancy with EGF: effects on wool growth and plasma concentrations of growth hormone, prolactin, placental lactogen and thyroxine and on foetal development. Acta Endocrinol (Copenh) 105:558–566Google Scholar
  63. Moore GPM, Wilkinson M, Panaretto BA, Delbridge LW, Posen S (1986) Epidermal growth factor causes hypocalcaemia in sheep. Endocrinology 118:1525–1529PubMedCrossRefGoogle Scholar
  64. Oliver RF (1966) Whisker growth after removal of the dermal papilla and lengths of the follicle in the hooded rat. J Embryol Exp Morphol 15:331–347PubMedGoogle Scholar
  65. Olsen EA, Weiner MS, De Long ER, Pinnell SR (1985) Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 13:185–192PubMedCrossRefGoogle Scholar
  66. Olsen EA, De Long ER, Weiner MS (1986) Dose-response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol 15:30–37PubMedCrossRefGoogle Scholar
  67. Orentreich N (1969) Scalp hair regeneration in man. In: Montagna W, Dobson RL (eds) Hair growth. Pergamon, Oxford (Advances in biology of skin, vol IX)Google Scholar
  68. Orrechia G, Rabbiosi G (1985) Treatment of alopecia areata with diphencyprone. Dermatologica 171:193–196CrossRefGoogle Scholar
  69. Pendry A, Alexander P (1982) Stimulation of hair growth on nude mice by cyclosporin A. In: White DJG (ed) Proceedings of an international conference on cyclosporin A. Cambridge. Elsevier Biomedical, AmsterdamGoogle Scholar
  70. Rampen FHJ (1985) Hypertrichosis: a side-effect of PUVA therapy. Arch Dermatol Res 278:82–83PubMedCrossRefGoogle Scholar
  71. Reynolds JEF (1982) Martindale the extra pharmacopoeia, 28th edn. The Pharmaceutical Press, LondonGoogle Scholar
  72. Rheinwald JG, Green H (1977) Epidermal growth factor and the mulitplication of cultured human epidermal keratinocytes.Nature 265:461–424CrossRefGoogle Scholar
  73. Rosenberg EW, Drake L (1976) Alopecia areata: discussion. Arch Dermatol 112:256PubMedCrossRefGoogle Scholar
  74. Rosenfield RL (1971) Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. J Clin Endocrinol Metab 32:717–728PubMedCrossRefGoogle Scholar
  75. Saunders TS, Fitzpatrick TB, Seiji M, Brunet P, Rosenbaum EE (1959) Decrease in human hair colour and feather pigment of fowl following chloroquine diphosphate. J Invest Dermatol 33:87–90PubMedCrossRefGoogle Scholar
  76. Schmidt JB, Huber J, Spona J (1985) Medroxyprogesterone acetate therapy in hirsutism. Br J Dermatol 113:161–165PubMedCrossRefGoogle Scholar
  77. Schweikert HU, Wilson JD (1974) Regulation of human hair growth by steroid hormones, i. Testosterone metabolism in isolated hairs. J Clin Endocrinol Metab 38:811–819PubMedCrossRefGoogle Scholar
  78. Schweikert HU, Milewich L, Wilson JD (1975) Aromatisation of androstenedione by isolated human hairs. J Clin Endocrinol Metab 40:313–417CrossRefGoogle Scholar
  79. Shapiro G, Evran S (1980) A novel use of spironolactone: treatment of hirsutism. J Clin Endocrinol Metab 51:429–432PubMedCrossRefGoogle Scholar
  80. Shuster S (1972) Primary cutaneous virilism or idiopathic hirsuties? Br Med J 2:285–286PubMedCrossRefGoogle Scholar
  81. Shuster S (1982) The sebaceous glands and primary cutaneous virilism. In: Jeffcoate SL (ed) Androgens and antiandrogen therapy. Wiley, ChichesterGoogle Scholar
  82. Simpson NB, Cunliffe WJ, Hodgins MB (1983) The relationship between the in vitro activity of 3β-hydroxysteroid dehydrogenase Δ 4–5 isomerase in human sebaceous glands and their secretory activity in vitro. J Invest Dermatol 81:139–144CrossRefGoogle Scholar
  83. Singh G, Lal S (1967) Hypertrichosis and hyperpigmentation with systemic psoralen treatment. Br J Dermatol 79:501–503PubMedCrossRefGoogle Scholar
  84. Stoll BA (1974) Evaluation of cyclophosphamide dosage schedules in breast cancer. Br J Cancer 24:475–483CrossRefGoogle Scholar
  85. Thomas JP, Oake RJ (1974) Androgen metabolism in the skin of hirsute women. J Clin Endocrinol Metab 38:19–22PubMedCrossRefGoogle Scholar
  86. Tosti A, Bardazzi F, De Padova MP, Caporieri GM, Melino M, Veronesi S (1985) Contact dermatitis to minoxidil. Contact Dermatitis 13:275–276PubMedCrossRefGoogle Scholar
  87. Tosti A, De Padora MP, Minghetti G, Veronesi S (1986) Therapies versus placebo in the treatment of patchy alopecia areata. J Am Acad Dermatol 15:209–210PubMedCrossRefGoogle Scholar
  88. Underhill R, Dewhurst J (1979) Further clinical experience in the treatment of hirsutism with cyproterone acetate. Br J Obstet Gynaecol 86:139–141PubMedCrossRefGoogle Scholar
  89. Uno H, Cappas A, Schlagel C (1985) Cyclic dynamics of hair follicles and the effect of minoxidil on the bald scalps of stumptailed macaques. Am J Dermatopatho l7:283–297CrossRefGoogle Scholar
  90. Vanderveen EC, Ellis CN, Kang S, Case P, Headington JT, Voorhees JJ, Swanson NA (1984) Topical minoxidil for hair regrowth. J Am Acad Dermatol 11:416–421PubMedCrossRefGoogle Scholar
  91. Vermorken AJM (1983) Reversal of androgenetic alopecia by minoxidil: lack of effect of simultaneously administered intermediate doses of cyproterone acetate. Acta Derm Venereol (Stockh) 63:268–269Google Scholar
  92. Warin AP, Hehir ME, Du Vivier A (1979) Alopecia areata treated with DNCB. Clin Exp Dermatol 4:385–387CrossRefGoogle Scholar
  93. Weiss VC, West DP, Mueller CE (1981) Topical minoxidil in alopecia areata. J Am Acad Dermatol 5:224–226PubMedCrossRefGoogle Scholar
  94. Weiss VC, West DP, Fu TS, Robinson LA, Cook B, Cohen RL, Chambers DA (1984) Alopecia areata treated with topical minoxidil. Arch Dermatol 120:457–463PubMedCrossRefGoogle Scholar
  95. Weissmann I, Hoffmann C, Wagner G, Plewig G, Braun-Falco O (1978) PUVA therapy for alopecia areata. Arch Dermatol Res 262:333–336PubMedCrossRefGoogle Scholar
  96. Wester RC, Maibach HI, Guy RH, Novak E (1984) Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser doppler velocimetry and photopulse plethysmography. J Invest Dermatol 82:515–517PubMedCrossRefGoogle Scholar
  97. Yen SSC (1980) The polycystic ovary syndrome. Clin Endocrinol (Oxf) 12:177–208CrossRefGoogle Scholar
  98. Zappacosta AR (1980) Reversal of baldness in a patient receiving minoxidil for hypertension. N Engl J Med 303:1480–1481PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • N. B. Simpson

There are no affiliations available

Personalised recommendations